InnoModels: What are the features of the in vivo tumor platform?

The In Vivo Tumor Experimental Platform from InnoModels Biotechnology is an advanced research technology designed to provide a reliable and efficient tool for cancer research and drug development. The following are some of the distinguishing features of the platform:

1. In vivo environment simulation: The platform is able to simulate the real environment of tumor development in living animals. This enables researchers to more accurately study key processes such as tumor growth, spread, invasion and treatment response.

2. Abundant Tumor Types: The platform supports many different types of tumor models, including transplanted tumor models, in situ tumor models, and so on. This diversity enables researchers to choose the tumor type that best suits their research objectives.

3. Personalized Experiment Design: InnoModels Biotechnology provides researchers with the service of personalized experiment design, adjusting the specific parameters of the tumor model according to their research needs to ensure the flexibility and controllability of the experiments.

4. Tumor Treatment Effectiveness Evaluation: The platform can be used to evaluate the effectiveness of various tumor treatments, including drug therapies, immunotherapies, and so on. Researchers can comprehensively assess treatment effects by monitoring indicators such as tumor growth, volume and metabolism.

5. High visualization and real-time monitoring: The experimental platform features high visualization, allowing researchers to monitor tumor growth and treatment effects in real time. This helps to adjust the experimental program in time and obtain more accurate research data.

6. Strict quality control: InnoModels Biotechnology conducts strict quality control on the in vivo tumor platform to ensure the reproducibility of each experiment and the reliability of the results. This is crucial to the validity of scientific research.

7. Customized Service: InnoModels Biotechnology provides customized service to adjust the characteristics of tumor models according to the specific needs of researchers in order to meet the individual requirements of different research projects.

By providing this advanced in vivo oncology platform, InnoModels Biotechnology provides scientists in the field of cancer research and treatment with a powerful tool that is expected to accelerate the process of new drug discovery and contribute to innovation in the field of cancer treatment. The application of this technology will contribute to a deeper understanding of tumor biology and provide strong support for the development of personalized therapeutic approaches.

about InnoModels Biotechnology (Beijing) Co., Ltd：InnoModels Biotech (Beijing) Co., Ltd. was founded by scientists from Novo Nordisk China R&D Center, Sino American Coronavirus, and Shanghai Jiao Tong University Institute of Immunology.InnoModels Biotech has domestic stability of the humanized mice immune system model (ihs) platform, and anthropogenic tumor allografts platform (symbol), focusing on tumor and tumor immune pharmacodynamics CRO services, translational medicine research service, individualized medicine, service transformation of new drug research and development enterprise, medical researchers, cancer patients, is dedicated to the research and development of tumor and tumor immunotherapy to provide close to the clinical trials of a new generation of animal models.